Cargando…
Cuproptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of early-stage lung adenocarcinoma patients
Background: Although a majority of early-stage lung adenocarcinoma (es-LUAD) patients have a favorable prognosis, there are still some cases with a risk of recurrence and metastasis. Cuproptosis is a new form of death that differs from other programmed cell death. However, no study has been reported...
Autores principales: | Tang, Yu, Li, Qifan, Zhang, Daoqi, Ma, Zijian, Yang, Jian, Cui, Yuan, Zhang, Aiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515444/ https://www.ncbi.nlm.nih.gov/pubmed/36186452 http://dx.doi.org/10.3389/fgene.2022.977156 |
Ejemplares similares
-
Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinoma
por: Lv, Yanju, et al.
Publicado: (2022) -
A novel defined cuproptosis-related gene signature for predicting the prognosis of lung adenocarcinoma
por: Zhang, Huizhe, et al.
Publicado: (2022) -
The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer
por: Li, Jia, et al.
Publicado: (2022) -
The cuproptosis related genes signature predicts the prognosis and correlates with the immune status of clear cell renal cell carcinoma
por: Sun, Peng, et al.
Publicado: (2022) -
Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma
por: Cong, Tianhao, et al.
Publicado: (2022)